Promentis Pharmaceuticals - Crunchbase Company Profile & Funding

Q: Who invested in Promentis Pharmaceuticals?

Promentis Pharmaceuticals has 8 investors including F-Prime And Aisling Capital.

Q: How much funding has Promentis Pharmaceuticals raised to date?

Promentis Pharmaceuticals has raised obfuscated.

Overview

Promentis Pharmaceuticals

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Promentis Pharmaceuticals

CB Rank

74037

Promentis Pharmaceuticals focuses on developing antipsychotic drugs to treat schizophrenia.

Founded

obfuscation

Private

Venture - Series Unknown

Milwaukee, Wisconsin, United States

11-50

www.promentispharma.com

Biotechnology

Medical

Pharmaceutical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Series C

OBF

obfuscation

Key People

Klaus Veitinger: Chief Executive Officer
Past Role: Symbiomix Therapeutics, CEO
John Mantsch: Founder

Details

Legal Name

Promentis Pharmaceuticals Inc.

Operating Status

Active

Company Type

For Profit

Founders

David A. Baker, John Mantsch

About the Company

Promentis Pharmaceuticals discovers, develops, and markets new drugs for the treatment of important human diseases, focusing initially on developing a new antipsychotic drug to treat schizophrenia. Promentis Pharmaceuticals was founded in 2006 and is based in Milwaukee, Wisconsin.

Phone Number

(414)238-2992

Contact Email

contact@promentispharma.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

SXC-2023

An oral compound targeting System xc- to address glutamatergic imbalance and oxidative stress in neuropsychiatric disorders, primarily trichotillomania.

Research & Development

Promentis Pharmaceuticals is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Promentis Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Promentis Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Promentis Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Promentis Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Promentis Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Promentis Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Promentis Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Promentis Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Promentis Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Promentis Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
F-Prime	Yes	Series C - Promentis Pharmaceuticals	—
F-Prime	Yes	Series C - Promentis Pharmaceuticals	—
F-Prime	Yes	Series C - Promentis Pharmaceuticals	—
F-Prime	Yes	Series C - Promentis Pharmaceuticals	—
F-Prime	Yes	Series C - Promentis Pharmaceuticals	—